Desuden var anæmi almindelig og misfarvning af huden (øget pigmentering) meget almindelig, når emtricitabin blev indgivet til pædiatriske patienter.
In addition anaemia was common and skin discolouration (increased pigmentation) was very common when emtricitabine was administered to paediatric patients.